Drug Interactions between digoxin and Entresto
This report displays the potential drug interactions for the following 2 drugs:
- Entresto (sacubitril/valsartan)
Interactions between your drugs
No interactions were found between digoxin and Entresto. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Digoxin is in the following drug classes: group V antiarrhythmics, inotropic agents.
- Digoxin is used to treat the following conditions:
- Entresto is in the drug class angiotensin receptor blockers and neprilysin inhibitors.
- Entresto is used to treat Heart Failure.
Drug and food interactions
Applies to: Entresto (sacubitril / valsartan)
If you are taking valsartan you should avoid potassium-containing salt substitutes or over-the-counter potassium supplements without first talking to your doctor. This can cause high levels of potassium in your blood. High levels of potassium can cause weakness, irregular heartbeat, confusion, tingling of the extremities, or feelings of heaviness in the legs. Call your doctor at once if you have any of these symptoms.
Applies to: digoxin
Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
For clinical details see professional interaction data.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|